BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22560877)

  • 1. μ-Opioid and 5-HT1A receptors heterodimerize and show signalling crosstalk via G protein and MAP-kinase pathways.
    Cussac D; Rauly-Lestienne I; Heusler P; Finana F; Cathala C; Bernois S; De Vries L
    Cell Signal; 2012 Aug; 24(8):1648-57. PubMed ID: 22560877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive interaction of 5-HT(1A) receptors with G-protein subtypes in CHO cells demonstrated by RNA interference.
    Rauly-Lestienne I; Lestienne F; Ailhaud MC; Binesse J; Newman-Tancredi A; Cussac D
    Cell Signal; 2011 Jan; 23(1):58-64. PubMed ID: 20727408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the mouse 5-hydroxytryptamine(1A) receptor in lipid microdomains depends on its palmitoylation and is involved in receptor-mediated signaling.
    Renner U; Glebov K; Lang T; Papusheva E; Balakrishnan S; Keller B; Richter DW; Jahn R; Ponimaskin E
    Mol Pharmacol; 2007 Sep; 72(3):502-13. PubMed ID: 17540717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective interactions of spinophilin with the C-terminal domains of the δ- and μ-opioid receptors and G proteins differentially modulate opioid receptor signaling.
    Fourla DD; Papakonstantinou MP; Vrana SM; Georgoussi Z
    Cell Signal; 2012 Dec; 24(12):2315-28. PubMed ID: 22922354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking.
    Renner U; Zeug A; Woehler A; Niebert M; Dityatev A; Dityateva G; Gorinski N; Guseva D; Abdel-Galil D; Fröhlich M; Döring F; Wischmeyer E; Richter DW; Neher E; Ponimaskin EG
    J Cell Sci; 2012 May; 125(Pt 10):2486-99. PubMed ID: 22357950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells.
    Merighi S; Gessi S; Varani K; Fazzi D; Stefanelli A; Borea PA
    Biochem Pharmacol; 2013 Aug; 86(4):487-96. PubMed ID: 23796752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 5-HT1A receptor-dependent cell survival by cAMP/protein kinase A: role of protein phosphatase 2A and Bax.
    Hsiung SC; Tin A; Tamir H; Franke TF; Liu KP
    J Neurosci Res; 2008 Aug; 86(10):2326-38. PubMed ID: 18459133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.
    Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D
    Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2.
    Jiao X; Gonzalez-Cabrera PJ; Xiao L; Bradley ME; Abel PW; Jeffries WB
    J Pharmacol Exp Ther; 2002 Oct; 303(1):247-56. PubMed ID: 12235258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
    Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
    Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
    J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally administered soymorphins, soy-derived opioid peptides, suppress feeding and intestinal transit via gut mu(1)-receptor coupled to 5-HT(1A), D(2), and GABA(B) systems.
    Kaneko K; Iwasaki M; Yoshikawa M; Ohinata K
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G799-805. PubMed ID: 20616303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
    Clark MJ; Traynor JR
    Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galpha(i) proteins, and ERK1/2 signaling.
    García-Fuster MJ; Ramos-Miguel A; Miralles A; García-Sevilla JA
    Neuropharmacology; 2008 Oct; 55(5):886-99. PubMed ID: 18657552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bell-shaped agonist activation of 5-HT
    Newman-Tancredi A; Cussac D; Ormière AM; Lestienne F; Varney MA; Martel JC
    Cell Signal; 2019 Nov; 63():109383. PubMed ID: 31376526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
    Lopez-Gimenez JF; Vilaró MT; Milligan G
    Mol Pharmacol; 2008 Nov; 74(5):1278-91. PubMed ID: 18703670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase.
    Kam AY; Chan AS; Wong YH
    J Neurochem; 2004 Apr; 89(2):391-402. PubMed ID: 15056283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.